1,721,005 research outputs found
Ethical Principles in Psychiatric Action
No full textThere is no specific psychiatric ethic. The ethical principles for practical actions in psychiatry have to be adapted on the basis of the generally accepted ethical principles, which are based on psychobiologically developed ethic of love: honesty, discretion, empathy, patience, distance, consistency, accountability, tolerance, economic neutrality
Electric shock-like sensations (paresthesia) on venlafaxin discontinuation
No full textA hospitalized 24-year-old female patient with severe recurrent depression experienced very unpleasant electric shock-like paresthesias in the extremities. The symptoms lasted seven days and probably can be considered as a venlafaxin discontinuation syndrome. The symptoms relieved on reexposition with venlafaxin. This case report shall call attention to the basic relevance of discontinuation syndromes as adverse drug reactions. In addition, the clinical relevance of unusual paresthesias shall be emphasized
Electric shock-like sensations (paresthesia) on venlafaxin discontinuation
No full textA hospitalized 24-year-old female patient with severe recurrent depression experienced very unpleasant electric shock-like paresthesias in the extremities. The symptoms lasted seven days and probably can be considered as a venlafaxin discontinuation syndrome. The symptoms relieved on reexposition with venlafaxin. This case report shall call attention to the basic relevance of discontinuation syndromes as adverse drug reactions. In addition, the clinical relevance of unusual paresthesias shall be emphasized
Atypical antipsychotics in Germany - an inventory
No full textThe use of atypical antipsychotics/neuroleptics for the treatment of schizophrenia is steadily increasing since their introduction in the 1990's. Currently, in the US, 79% of all prescriptions of antipsychotics in this indication are issued for atypicals. In contrast, atypicals are issued in only 45% of these prescriptions in Germany, a lower rate compared to all other North-American and European countries assessed, with the exception of France. The therapeutic notice of the German "Bundesausschuss der Arzte und Krankenkassen" according to Nr. 14 AMR (Drug Guidelines) issued in 2002 states that a general preference for atypicals is currently not justified and that their use would be linked to higher costs in comparison to typical neuroleptics. This contradicts recommendations in important international and national guidelines. In contrast, in the present article we would like to demonstrate that recent data regarding efficacy, tolerability, quality of life and cost effectiveness indeed build a solid foundation in favor of a general recommendation of atypicals
Atypical antipsychotics in Germany - an inventory
No full textThe use of atypical antipsychotics/neuroleptics for the treatment of schizophrenia is steadily increasing since their introduction in the 1990's. Currently, in the US, 79% of all prescriptions of antipsychotics in this indication are issued for atypicals. In contrast, atypicals are issued in only 45% of these prescriptions in Germany, a lower rate compared to all other North-American and European countries assessed, with the exception of France. The therapeutic notice of the German "Bundesausschuss der Arzte und Krankenkassen" according to Nr. 14 AMR (Drug Guidelines) issued in 2002 states that a general preference for atypicals is currently not justified and that their use would be linked to higher costs in comparison to typical neuroleptics. This contradicts recommendations in important international and national guidelines. In contrast, in the present article we would like to demonstrate that recent data regarding efficacy, tolerability, quality of life and cost effectiveness indeed build a solid foundation in favor of a general recommendation of atypicals
- …
